Mokari Atabak

Chief Financial Officer at CORT

Sold, on record
$18.7M
Dollars the filings state
Form 4 sales
4
Latest Jul 30, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CORTCORCEPT THERAPEUTICS INCChief Financial Officer

Sales by reason

4
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CORTRoutine
    Jun 1 2026

    Sold 40,000 shares at $70.00 ($2.8M)

    Mokari Atabak, Chief Financial Officer

    10b5-1 planSold 72.4% of holdings ($3.9M position)15,257 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale CORTRoutine
    Jun 15 +14 days

    Sold 40,000 shares at $81.15 ($3.2M)

    Mokari Atabak, Chief Financial Officer

    10b5-1 planSold 71.3% of holdings ($4.6M position)16,130 shares leftFiling

  3. 3 Form 4 sale CORTRoutine
    Jul 15 +30 days

    Sold 40,000 shares at $87.71 ($3.5M)

    Mokari Atabak, Chief Financial Officer

    10b5-1 planSold 71.3% of holdings ($4.9M position)16,130 shares leftFiling

  4. 4 Form 4 sale CORTRoutine
    Jul 30 +15 days

    Sold 80,000 shares at $114.72 ($9.2M)

    Mokari Atabak, Chief Financial Officer

    10b5-1 planSold 83.2% of holdings ($11M position)16,130 shares left2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Mokari Atabak
Source
Jul 30, 2026CORTChief Financial OfficerForm 4 sale80,000$9.2M83.2%RoutineSEC
Jul 15, 2026CORTChief Financial OfficerForm 4 sale40,000$3.5M71.3%RoutineSEC
Jun 15, 2026CORTChief Financial OfficerForm 4 sale40,000$3.2M71.3%RoutineSEC
Jun 1, 2026CORTChief Financial OfficerForm 4 sale40,000$2.8M72.4%RoutineSEC